APA ציטוט

Schönfeld, K., Herbener, P., Zuber, C., Häder, T., Bernöster, K., Uherek, C., & Schüttrumpf, J. (2018). Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models. Pharm Res.

Citação norma Chicago

Schönfeld, Kurt, Peter Herbener, Chantal Zuber, Thomas Häder, Katrin Bernöster, Christoph Uherek, and Jörg Schüttrumpf. "Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models." Pharm Res 2018.

ציטוט MLA

Schönfeld, Kurt, et al. "Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models." Pharm Res 2018.